| | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C12H19N3O8 |
| Molar mass | 333.297 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cartalax (Ala-Glu-Asp, T-31, AED) is a tripeptide derivative developed in Russia. It has anti-aging effects in vitro and in animal models, and has been sold in Russian-speaking countries as well as more broadly over the internet as a supposed treatment for conditions such as arthritis, though only limited studies in humans have been published. [1] [2] [3] [4] [5] [6] [7]